KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 170 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,072 | -25.1% | 800 | 0.0% | 0.00% | – |
| Q2 2023 | $1,432 | +47633.3% | 800 | -7.0% | 0.00% | – |
| Q1 2023 | $3 | 0.0% | 860 | +7.5% | 0.00% | – |
| Q4 2022 | $3 | -100.0% | 800 | -86.0% | 0.00% | – |
| Q3 2022 | $26,000 | +550.0% | 5,700 | +612.5% | 0.00% | – |
| Q2 2022 | $4,000 | -33.3% | 800 | 0.0% | 0.00% | – |
| Q1 2022 | $6,000 | -14.3% | 800 | 0.0% | 0.00% | – |
| Q4 2021 | $7,000 | +40.0% | 800 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | -37.5% | 800 | 0.0% | 0.00% | – |
| Q2 2021 | $8,000 | -81.4% | 800 | -80.2% | 0.00% | – |
| Q1 2021 | $43,000 | -31.7% | 4,050 | 0.0% | 0.00% | – |
| Q4 2020 | $63,000 | +23.5% | 4,050 | +15.7% | 0.00% | – |
| Q3 2020 | $51,000 | +218.8% | 3,500 | +311.8% | 0.00% | – |
| Q2 2020 | $16,000 | +45.5% | 850 | +44.1% | 0.00% | – |
| Q1 2020 | $11,000 | – | 590 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $35,031,000 | 23.03% |
| Palo Alto Investors LP | 5,267,652 | $81,543,000 | 4.28% |
| Fairmount Funds Management LLC | 702,351 | $10,872,000 | 3.89% |
| Birchview Capital, LP | 188,000 | $2,910,000 | 1.68% |
| Mesirow Financial Investment Management, Inc. | 22,303 | $345,250,000 | 1.09% |
| EMERALD ADVISERS, LLC | 1,822,781 | $28,217,000 | 0.94% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,661,236 | $25,716,000 | 0.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,552,504 | $24,033,000 | 0.85% |
| Altium Capital Management LP | 133,951 | $2,074,000 | 0.77% |
| Hood River Capital Management LLC | 931,754 | $14,424,000 | 0.48% |